Victory Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-172,914	Closed	-$18.6M	–	2645
2023 Q1	$18.6M	Buy	172,914 +54,507	+46%	+$5.85M	0.02%	814
2022 Q4	$13M	Buy	118,407 +110,292	+1,359%	+$12.1M	0.02%	939
2022 Q3	$479K	Buy	+8,115	New	+$479K	﹤0.01%	2072